Kenshi Yamasaki

34PUBLICATIONS
43CO-AUTHORS
AutoimmunityJapanese languageCancer diagnosisBiomolecular modelling and designInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 10, 2026
Safety and Effectiveness of Adalimumab for the Treatment of Pyoderma Gangrenosum: A 52-Week Real-World Prospective Observational Study.

|Mar 13, 2026
An Attempt to Establish the Consensus Regarding the Diagnosis, Classification, and Treatment of Rosacea in Japan Using a Modified Delphi Method: The Japan Rosacea Consensus.

Kenshi Yamasaki, Nobukazu Hayashi, Hiroaki Hayashi

|Jan 05, 2025
Deep learning-based histopathological assessment of tubulo-interstitial injury in chronic kidney diseases.

Nonoka Suzuki, Kaname Kojima, Silvia Malvica

|Nov 13, 2024
Real-world safety and effectiveness of adalimumab in patients with pyoderma gangrenosum: Interim analysis of a post-marketing observational study in Japan.

Toshiyuki Yamamoto, Keiichi Yamanaka, Kenshi Yamasaki

|Jun 27, 2024
Anti-Melanogenic Activity of Ethanolic Extract from Garcinia atroviridis Fruits Using In Vitro Experiments, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.

Aman Tedasen, Anchalee Chiabchalard, Tewin Tencomnao

|Jan 08, 2023
The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors.

Ryo Amagai, Toshiya Takahashi, Hitoshi Terui

Pageof 6

Frequent Collaborators

8 joint publications

Hitoshi Terui

4 joint publications

Toshiya Takahashi

4 joint publications

Toshiyuki Yamamoto

4 joint publications

Keiichi Yamanaka